🇦🇹 Austria Country × Condition
endometrial cancer Clinical Trials in Austria
Active clinical trials for endometrial cancer with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3, Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT06989112 Phase 3
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Enrollment
600 pts
Country
🇦🇹 Austria
AstraZeneca
View Trial → NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Enrollment
268 pts
Country
🇦🇹 Austria
Kartos Therapeutics, Inc.
View Trial → Frequently Asked Questions
How many endometrial cancer clinical trials are active in Austria?
There are currently 2 active clinical trials for endometrial cancer with sites in Austria, of which 2 are actively recruiting patients.
How can I join a endometrial cancer clinical trial in Austria?
To join a endometrial cancer clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are endometrial cancer trials in Austria?
Active endometrial cancer trials in Austria span Phase 3, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology